Yüklüyor......
Combined CB2 Receptor Agonist and Photodynamic Therapy Synergistically Inhibit Tumor Growth in Triple Negative Breast Cancer
Triple negative breast cancer (TNBC) is the deadliest form of breast cancer because compared with other types of breast cancer, it is more aggressive, diagnosed at later stage and more likely to develop recurrence. Many patients do not experience adequate tumor control after current clinical treatme...
Kaydedildi:
| Yayımlandı: | Photodiagnosis Photodyn Ther |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6289793/ https://ncbi.nlm.nih.gov/pubmed/30240926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pdpdt.2018.09.006 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|